---
figid: PMC5385204__10555_2017_9662_Fig6_HTML
figtitle: Genomic alterations in malignant melanoma
organisms:
- Homo sapiens
- Saccharomyces cerevisiae
pmcid: PMC5385204
filename: 10555_2017_9662_Fig6_HTML.jpg
figlink: /pmc/articles/PMC5385204/figure/Fig6/
number: F6
caption: Pathway analysis of genomic alterations in malignant melanoma. a Oncogenic
  alterations of MAPK pathway is illustrated by somatic mutations, SCNAs, and transcriptional
  alterations (from inner box to outer box; see legend). Genomic activation and inactivation
  are shown in red and blue, respectively. Genomic co-occurrence and mutual exclusivity
  points to multiple parallel signals within pathway. b MAPK pathway. c PI3K pathway.
  d WNT and G protein signaling. e Cell cycle, senescence, and apoptotic signaling.
  Signaling maps of melanoma and melanogenesis highlight predominant oncogenes and
  tumor suppressors, in red and blue, respectively
papertitle: Precision medicine driven by cancer systems biology.
reftext: Fabian V. Filipp. Cancer Metastasis Rev. 2017;36(1):91-108.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9140745
figid_alias: PMC5385204__F6
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC5385204__F6
ndex: 5fcac3c1-dea7-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5385204__10555_2017_9662_Fig6_HTML.html
  '@type': Dataset
  description: Pathway analysis of genomic alterations in malignant melanoma. a Oncogenic
    alterations of MAPK pathway is illustrated by somatic mutations, SCNAs, and transcriptional
    alterations (from inner box to outer box; see legend). Genomic activation and
    inactivation are shown in red and blue, respectively. Genomic co-occurrence and
    mutual exclusivity points to multiple parallel signals within pathway. b MAPK
    pathway. c PI3K pathway. d WNT and G protein signaling. e Cell cycle, senescence,
    and apoptotic signaling. Signaling maps of melanoma and melanogenesis highlight
    predominant oncogenes and tumor suppressors, in red and blue, respectively
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KITLG
  - NGF
  - NGFR
  - SERPINA4
  - KRAS
  - HRAS
  - NRAS
  - PLK3
  - BRAF
  - AKT3
  - MAP2K3
  - MAP2K4
  - MAP2K5
  - MAP2K6
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - MTOR
  - MYC
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - ASIP
  - PARD3
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - HLA-B
  - CRYGC
  - CRYGEP
  - CCL1
  - CCL2
  - CCL3L1
  - CCL3L3
  - CCL4L1
  - CCL4L2
  - CCL5
  - CCL7
  - CCL8
  - CCL11
  - CCL13
  - CCL14
  - CCL15
  - CCL16
  - CCL17
  - CCL18
  - CCL19
  - CCL20
  - CCL21
  - CCL22
  - CCL24
  - CCL25
  - CCL26
  - CCL27
  - CCL28
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - CXCL9
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL16
  - CXCL17
  - XCL1
  - XCL2
  - CCL3
  - CCL4
  - MC1R
  - GNAS
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - CDKN2A
  - S100A9
  - CDK2AP2
  - SUB1
  - RPP14
  - LAMTOR2
  - SF3B6
  - H3P8
  - H3P10
  - PRKACA
  - PRKCA
  - EZH2
  - GSK3B
  - MDM2
  - ATF4
  - TP53
  - BOK
  - NDRG1
  - EP300
  - TNFRSF1A
  - TNFRSF1B
  - TNFRSF4
  - TNFRSF8
  - TNFRSF9
  - TNFRSF10A
  - TNFRSF10B
  - TNFRSF10C
  - TNFRSF10D
  - TNFRSF11A
  - TNFRSF11B
  - TNFRSF12A
  - TNFRSF13B
  - TNFRSF13C
  - TNFRSF14
  - TNFRSF17
  - TNFRSF18
  - TNFRSF19
  - TNFRSF21
  - TNFRSF25
  - HNF4A
  - CREB3L2
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - TFAP2A
  - Cancer
  - Lung cancer
  - Melanoma
---
